NIMG-30. ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101)

The current standard of care for glioblastoma (GBM; WHO grade IV glioma) is maximal safe resection followed by radiation therapy (RT) with concurrent and adjuvant chemotherapy. Despite this aggressive treatment, the median survival remains only 15 months. Thus, there is a need for better treatment o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Gurbani, Saumya, Sengupta, Soma, Voloschin, Alfredo, Liang, Zhongxing, Yoon, Younghyoun, Vega, Jose Enrique Velazquez, Holder, Chad A, Olson, Jeffrey J, Shu, Hui-Kuo, Shim, Hyunsuk
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692314/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.605
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker